Results of studies that focused on bodyweight and composition indicate an increase in bodyweight of 1—3 kg per year, with an increase in fat mass 2—4 kg and a decrease in lean body mass 2—4 kg after 1 year of cross-sex hormone treatment. However, details of bone shape change throughout life, with bones becoming heavier and more deeply sculptured under the influence of androgens, and HRT does prevent such changes from progressing further. Estrone Estriol Estetrol Ethinylestradiol Conjugated estrogens Esterified estrogens Estrone sulfate Estropipate piperazine estrone sulfate. Both testosterone patchescreams and gels are available. There are two types of GnRH modulators:
Generally after the first cycle, menses are greatly reduced or eliminated.
Oestrogen and anti-androgen therapy for transgender women
Gender dysphoria often presents in childhood. Indian J Endocrinol Metab. A renaissance for parenteral estrogen]. This is especially likely with hair growth from previously bald areas. Conversely, inhibitors of CYP3A4 and other cytochrome P enzymes, such as cimetidineclotrimazolegrapefruit juiceitraconazoleketoconazoleand ritonaviramong others, may increase circulating levels of these medications and thereby increase their effects.
The occurrence of multiple meningiomas has been reported in association with longer-term use ie, use over several years of cyproterone at doses of 25 mg daily or higher. The American Journal of Surgical Pathology. Retrieved 17 January Peak levels for patients taking parenteral testosterone can be measured 24 — 48 h after injection. Inexpensive Oestradiol levels can be monitored.